XANTUS-EL: A real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation in Eastern Europe, Middle East, Africa and Latin America

BACKGROUND: The prospective, observational XANTUS study demonstrated low rates of stroke and major bleeding in real-world rivaroxaban-treated patients with non-valvular atrial fibrillation (NVAF) from Western Europe, Canada and Israel. XANTUS-EL is a component of the overall XANTUS programme and enr...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez, Carlos Arturo Areán, Lanas, Fernando, Radaideh, Ghazi, Kharabsheh, Suleiman M., Lambelet, Marc, Viaud, Marco Antonio Lavagnino, Ziadeh, Naser Samih, Turpie, Alexander G.G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Egyptian Society of Cardiology 2018
Materias:
Arrhythmia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303362/
https://www.ncbi.nlm.nih.gov/pubmed/30591748
http://dx.doi.org/10.1016/j.ehj.2018.09.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303362/
https://www.ncbi.nlm.nih.gov/pubmed/30591748
http://dx.doi.org/10.1016/j.ehj.2018.09.002

Ejemplares similares